MAPT and Alzheimer disease: These findings suggest a complex interplay between Aβ, tau, and neurodegeneration which may differ at the early and late stages of AD (Harrison, 2021); thus, measurement of both pathologies seems to be required for investigating the relationship between AD pathologies and neurodegeneration.